Cerebellar neurocan gene expression is a common pathogenic factor of trigeminal neuralgia and depression Authors: Zhangying Zeng, Jianwei Jiang, Xuemei Wu, Xinyue Liao, Yiqian Wang, Li Zhao, Feng Wang, Shitao Rao, Daoshu Luo Published: 2025 ABSTRACT BackgroundTrigeminal neuralgia (TN) is a severe neuropathic pain disorder characterized by sudden, electric shock-like facial pain. It frequently co-occurs with depression and these conditions often exacerbate each other. However, their shared pathogenic mechanisms remain poorly understoodMethodsIn this study, neuroimaging data were integrated with whole-genome sequencing data to identify common genetic risk factors. Initially, single nucleotide polymorphisms (SNPs) associated with both conditions were identified through whole-genome analysis. Gene-tissue associations were then elucidated using the S-PrediXcan and summary data-based Mendelian Randomization (SMR) methods. These findings were further validated through neuroimaging analysis and animal experiments.ResultsWhole-genome analysis identified SNPs shared by TN and depression. The neurocan (NCAN) gene was significantly associated with both disorders and showed a cerebellum-specific expression pattern. Neuroimaging revealed significant differences in brain function and structure between TN and depression patients, primarily localized in the temporal lobe, frontal lobe, and cerebellum. Animal experiments corroborated these findings, showing that elevated cerebellar NCAN expression is closely linked to the onset and progression of both TN and depression.ConclusionsThe study identifies the NCAN gene and cerebellar dysfunction as shared potential pathogenic factors between TN and depression. These findings provide new insights into the common mechanisms underlying these comorbid conditions and suggest potential implications for developing targeted therapeutic strategies.Graphical Abstract Supplementary InformationThe online version contains supplementary material available at 10.1186/s10194-025-02254-2. Introduction Trigeminal Neuralgia (TN), one of the most severe neuropathic pains encountered clinically, is characterized by sudden, intense, and transient facial pain with recurrent attacks [1, 2]. This type of severe facial pain is typically described as sharp, stabbing, or resembling an electric shock, and may occasionally be accompanied by twitching spasms of the facial muscles. According to the International Association for the Study of Pain (IASP), pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage, highlighting its subjective nature. A simple physical injury may not fully account for the complexity of pain [3]. Depression, a mood disorder marked by persistent emotional deterioration [4], has been shown in extensive studies to prolong and intensify pain [5, 6]. Current clinical and preclinical research focus on the mechanisms underlying the comorbidity of chronic pain and depression, as well as the efficacy of antidepressant drugs in pain relief [7]. Identifying shared factors in TN and depression may therefore provide valuable insights for integrated treatment strategies. Evidence indicates that TN exhibits significant familial aggregation, underscoring the importance of genetic factors in its etiology [8]. A whole-exome sequencing study of 290 TN patients revealed an enrichment of rare deleterious mutations in genes related to gamma-aminobutyric acid (GABA) receptor-binding [9]. Nevertheless, genome-wide investigations into TN pathogenesis remain limited. In contrast, genome-wide association studies (GWAS) have been extensively applied in depression research. A large-scale GWAS study comprising over 1.2 million individuals—including 1,154,267 of European (of whom 340,591 were cases) and 59,600 of African ancestry (of whom 25,843 were cases) identified multiple genetic loci associated with depression [10]. Another study linked hypothalamic expression of the NEGR1 gene and nucleus accumbens expression of the DRD2 gene to depression [10], suggesting region-specific gene expression alterations in the brain. Similar tissue-specific gene expression patterns have been observed in chronic pain [11]. Leveraging these insights, we integrated GWAS summary statistics with S-PrediXcan and summary data-based Mendelian Randomization (SMR) to identify gene-tissue associations shared between TN and depression. We further analyzed the expression profiles of these genes across brain regions to pinpoint comorbid genes with tissue-specific characteristics. Resting-state functional magnetic resonance imaging (rs-fMRI) studies identified abnormal neural activity in multiple brain regions in TN patients, including the thalamus, postcentral gyrus, cerebellum, anterior cingulate cortex, and other cortical and subcortical areas [12–15]. Similarly, fMRI studies in depression have linked the disorder to functional changes in regions such as the left amygdala, right insula, and right inferior frontal gyrus [16]. Despite these parallel findings, whether TN and depression share convergent functional alterations in the brain remains unclear. This study aims to identify shared pathogenic factors between trigeminal neuralgia and depression through integrated analyses of genome-wide data, neuroimaging, and animal experiments, with a focus on exploring tissue-specific gene expression patterns and their roles in the comorbidity of the two disorders. Materials and methods Genome analysis Genome-wide association analyses summary statistics For TN, the genotyping and phenotype data were obtained from the UK Biobank. We included 508 clinically confirmed cases (ICD-10 code: G50.0) and 2,540 matched controls without neurological disorders. Controls were selected using the propensity score matching (PSM) strategy that matched by age and sex at a ratio of 1:5. Detailed criteria for case and control selection were provided in the Supplementary Materials and Methods. All included individuals were of European ancestry to minimize population stratification bias. UK Biobank participants were genotyped using either the UK BiLEVE Axiom Array or the UK Biobank Axiom Array (>95% marker overlap). Genotypes were centrally imputed using the Haplotype Reference Consortium (HRC) and UK10K/1000 Genomes reference panels. For downstream analyses, we retained variants with INFO ≥ 0.3 and MAF ≥ 1%. Genome-wide association analyses were performed using GCTA (v1.94.1) [17]. A genetic relationship matrix (GRM) was constructed using imputed dosage data. To reduce cryptic relatedness, we removed one individual from each pair with a kinship coefficient > 0.1 and recalculated the GRM among unrelated individuals. Association testing was conducted using the fastGWA-GLMM framework, which fits a generalized linear mixed model to account for both population structure and sample relatedness. Age, sex, and the top 10 principal components were included as covariates. To assess residual population stratification, we calculated the genomic inflation factor using the LDSC program, which yielded λGC = 0.996, indicating minimal inflation and suggesting that stratification effects were adequately controlled. For depression, we obtained publicly available GWAS summary statistics released by the Psychiatric Genomics Consortium (PGC) [18]. This dataset is based on a meta-analysis of three large cohorts: 23andMe_307k [19], UK Biobank [20], and PGC_139k [21]. Detailed information about case and control in this meta-analysis was provided in the Supplementary Materials and Methods. Prior to downstream analyses, we performed standard preprocessing steps to enhance data reliability, including harmonization of SNP identifiers, removal of duplicated variants, and exclusion of SNPs located on sex chromosomes. Identify specific genes associated with genes and tissues This study utilized the S-PrediXcan method within the framework of whole-transcriptome association analysis and SMR to identify trait-associated genetic regulatory gene expression, thereby providing a directional and tissue-specific context for further investigation. S-PrediXcan is a transcriptome-wide association analysis method that leverages summary statistics. It aims to identify genes associated with complex traits or diseases by integrating gene expression prediction models with summary-level data derived from GWAS. For the S-PrediXcan analyses, we focused on brain tissues to identify genetically regulated gene expression associated with TN and depression, respectively. Specifically, we utilized expression prediction weights derived from the GTEx v8 reference panel across 13 brain regions, including the frontal cortex, anterior cingulate cortex, cortex, amygdala, hippocampus, hypothalamus, caudate (basal ganglia), nucleus accumbens, putamen (basal ganglia), substantia nigra, cerebellar hemisphere, cerebellum, and spinal cord (C1). To ensure ancestry consistency, we applied linkage disequilibrium (LD) reference data from the European subset of the 1000 Genomes Project Phase 3 [22], which matches the ancestry of our GWAS samples. Genes with a gene association level of p < 0.05 are identified as specific genes involved in gene-tissue associations. SMR is a Mendelian randomization method that leverages summary data, enabling the utilization of GWAS summary statistics for causal inference. The central objective is to deduce the causal relationship between gene expression and traits by examining the association between genetic instrumental variables of gene expression levels (such as eQTLs) and target traits. For the SMR analyses, we similarly used cis-eQTL summary statistics from GTEx v8 across the same 13 brain regions, covering SNPs located within ±1 Mb of transcription start sites [23]. The European reference genome panel from the 1000 Genomes Project Phase 3 as the LD reference to ensure matching ancestry and reduce bias due to population stratification. Furthermore, genes with p < 0.05 and P_HEIDI > 0.05 are identified as specific genes for gene-tissue associations. Gene pathway enrichment analysis The Kyoto Encyclopedia of Genes and Genomes (KEGG) serves as a critical resource for elucidating the molecular mechanisms underlying biological processes and is extensively utilized in multi-omics research. This study employed the DAVID tool (http://david.abcc.ncifcrf.gov/) to perform gene function annotation analysis on specific genes associated with tissues, using the entire human gene set as the background gene list. The resulting data were visualized using the ggplot package in R software (Version 4.3.1). Radiomics analysis Source of image data The rs-fMRI data utilized in this study were sourced from the OpenNeuro database (OpenNeuro Accession Numbers: DS002748 [24] and DS005713 [25]). Specifically, the DS002748 dataset comprised rs-fMRI data from 51 individuals diagnosed with depression and 21 healthy controls (HC), collected at the Novosibirsk Tomography Center. The diagnosis of depression was made by an experienced psychotherapist according to the International Classification of Diseases (ICD-10). And more the detailed screening criteria have been described in the previous study [24]. The DS005713 dataset was collected at the Federal Neurosurgical Center, Novosibirsk, Russia. TN patients were adults diagnosed based on the International Classification of Headache Disorders Criteria (3rd edition). A total of 53 TN patients and 22 healthy controls were excluded from the analysis due to the presence of other underlying diseases, significant small vessel disease (Fazekas grade 2 or 3), and other confounding factors. The screening process is illustrated in Fig. 1. Ultimately, 58 TN patients and 26 healthy controls were included in the final analysis.Fig. 1TN’s fMRI data filtering. A graphical representation of the stepwise process for selecting patients and healthy volunteers participating in this study, based on inclusion and exclusion criteria TN’s fMRI data filtering. A graphical representation of the stepwise process for selecting patients and healthy volunteers participating in this study, based on inclusion and exclusion criteria The detailed scanning parameters of the DS002748 and DS005713 datasets have been described in the previous studies [24, 25]. rs-fMRI data preprocessing and analysis This study employed the GRETNA toolbox in Matlab 2020a and the ANTs software for the preprocessing of rs-fMRI data. The detailed procedures are outlined as follows: (1) removal of the first five volumes to mitigate potential instability; (2) time slice correction and head motion correction: subjects with head motion exceeding or equal to 2 mm were filtered out; (3) spatial normalization into the Montreal Neurological Institute (MNI) space with the ANTs software; (4) dimensionality reduction and band-pass filtering (0.01–0.08 Hz); (5) regression of covariates associated with head motion, white matter, and cerebrospinal fluid noise signals. After the preprocessing was completed, the RESTplus toolbox was utilized to project the data onto the Anatomical Automatic Labeling (AAL) template. Subsequently, the blood oxygen level-dependent (BOLD) time series of 116 brain regions were extracted and evaluated. The average BOLD time series from all voxels within each brain region was considered as the representative signal for that region, which was further used for the computation of amplitude of low-frequency fluctuation (ALFF), fractional ALFF (fALFF), regional homogeneity (ReHo), and functional connectivity (FC). Following the extraction of ALFF, fALFF,and ReHo values for each voxel, these values were normalized by z-score to improve the normality. Then zALFF, zfALFF and smoothed zReHo (szReHo) values were used for subsequent analysis. Functional network construction In this study, the network analysis module of GRETNA software was employed to analyze functional networks properties. The whole brain was divided into 116 regions according to the AAL atlas. Pearson correlation coefficient between the time series of each node pair was calculated. The zFC data, which had undergone Fisher-Z transformation, were input as a weighted undirected functional connectivity matrix. An appropriate sparsity threshold was calculated and applied to convert the matrix into a binary form, thereby minimizing the impact of spurious or weak functional connections. Several key characteristics of the brain network were computed within the defined threshold range: global attributes including small-world properties (σ), and local attributes such as clustering coefficient (CC), shortest path length (SPL), nodal efficiency (NE), nodal local efficiency (NLE), degree centrality (DC), and betweenness centrality (BC). These features collectively describe the functional features of the brain network. A value of σ > 1 indicates the presence of small-world properties, which reflect a network state that is both locally and globally efficient. Small-world networks represent an intermediate state between regular and random networks, integrating the topological advantages of both. Animal experiment verification Experimental animal Twelve adult male Sprague-Dawley (SD) rats, weighing 160 ± 20 g, were procured from the Laboratory Animal Center of Fujian Medical University [License No.: SYXK (Min) 2020–0005]. The rats were maintained under controlled environmental conditions, including a temperature of 22–25 °C and a 12:12 h light-dark cycle, with ad libitum access to water and food. They were randomly allocated into the surgical group (TN, n = 6) and the sham operation group (Sham, n = 6). To eliminate potential subjective biases, all behavioral tests follow the double-blind principle. Neither the experimenter conducting the test nor the experimenter responsible for recording have knowledge of the grouping of the animals during the data collection stage to ensure the objectivity of the data recording and the fairness of the result analysis. This study was performed in strict adherence to the protocols approved by the Animal Ethics Committee of Fujian Medical University and followed the guidelines for the use of experimental animals established by the IASP. TN rat model of trigeminal nerve root chronic compression The TN rat model was established according to our previous study. A semicircular skin incision was made along the upper margin of the right orbit after being anesthetized with alfentanil (300 mg/kg, i.p.). The right infraorbital nerve within the infraorbital groove was exposed surgically through an approach along the medial orbital wall. Then, a custom-made curved hollow stainless steel catheter with an outer diameter of 0.6 mm and an inner diameter of 0.5 mm was inserted for further manipulation. A nylon guide wire with a diameter of approximately 0.4 mm and a length of 1.5 to 2 mm at the front end was inserted. Then, a flexible stainless steel wire was placed at the rear end contacting with the nylon guide wire. The catheter was gradually advanced along the infraorbital nerve toward the trigeminal root entry zone (TREZ) region. The nylon guide wire was carefully extruded to achieve the desired compression effect. Subsequently, the catheter was withdrawn with caution. For the Sham group, the right infraorbital nerve was exposed without any compression applied to the trigeminal nerve root. Following the procedure, the incision was closed with sutures, and erythromycin ointment was evenly applied to the surgical site to promote healing. Detection of orofacial mechanical pain The mechanical allodynia behavior in the rat orofacial region was assessed using von Frey filaments. Baseline measurements were obtained through continuous testing over a 3-day period prior to surgery. Assessments were conducted on the day preceding the surgery and at 7, 14, 21, and 28 days post-surgery. Facial fur was shaved, and the skin was prepared one day prior to each behavioral test. Animals were acclimatized to the testing environment for 30 minutes on each experimental day. Testing was initiated using the von Frey filaments with the lowest pressure. Each filament was tested five times with a 30-second inter-stimulus interval, and responses to mechanical stimulation were recorded. A positive response was defined as three or more behavioral reactions out of five trials for a given filament, and its scale was documented. All animals underwent three consecutive behavioral tests with at least 30 seconds between each. Open field test The open field test is a widely recognized and classical experimental method used to assess the emotional behavior of animals. The experimental apparatus consisted of a rectangular open box measuring 100 cm × 100 cm × 40 cm, with white walls and a black floor. All animals were assessed on the 28th day post-surgery. The experiment was performed in a quiet setting with dim lighting. Before the experiment, the rats were placed in the behavioral laboratory for one hour for adaptation. Each rat was gently placed in the central area of the open box and allowed to move freely for 5 min. Key observation indicators included total movement distance and movement speed. Following each trial, the box was promptly cleaned with low-concentration alcohol. Subsequent trials commenced only after the alcohol had fully evaporated. Elevated plus maze test The elevated plus maze (EPM) test is a well-established method for assessing emotional behavior in animals. The apparatus consisted of two enclosed arms (50 cm × 10 cm), two open arms (50 cm × 10 cm), and a central platform (10 cm × 10 cm). The entire apparatus was elevated 50 cm above the ground. Measurements were conducted on the 28th day post-surgery for both the Sham and TN groups. Rats were placed in the center of the maze facing the open arms. Using animal behavior analysis software, the number of entries into the open arms and the duration of time spent in the open arms within a 5-minute period were recorded. Subsequently, the percentages of time spent in the open arms were calculated. The primary observation index was the percentage of time spent in the open arms, which served as an indicator for evaluating depressive-like behavior. The device was cleaned with low-concentration alcohol, and thoroughly dried prior to the next experiment. RNA extraction and RT-PCR verification of mRNA transcriptional level Total RNA was extracted from cerebellar tissues (n = 3 per group) using TRIzol reagent. cDNA was synthesized using a reverse transcription kit (Vazyme, Cat#R223). Quantitative PCR was performed with a SYBR Green kit (Vazyme, Cat#Q311-02) on a real-time PCR system. GAPDH served as the internal control, and relative gene expression was calculated using the 2-∆∆Ct method. Primer sequences are listed in Table 1.Table 1Primer for real-time qPCRGenesPrimer sequenceProduct size (bp)Neurocan5’-GAGAACAACCCTTGTCTGCACG-3’2223’-TTCTGTGTCCTTCTCGCACA-5’Gapdh5’-GTAAGCAGTTGGTGGTGCAG-3’2633’-TCATTGACCTCAACTACATGGT-5’ Table 1Primer for real-time qPCRGenesPrimer sequenceProduct size (bp)Neurocan5’-GAGAACAACCCTTGTCTGCACG-3’2223’-TTCTGTGTCCTTCTCGCACA-5’Gapdh5’-GTAAGCAGTTGGTGGTGCAG-3’2633’-TCATTGACCTCAACTACATGGT-5’ Primer for real-time qPCR Western blot Protein was extracted from cerebellar tissues (n = 5 per group) and quantified by BCA assay. Equal amounts of protein were separated by 6% SDS-PAGE and transferred to PVDF membranes. After blocking, membranes were incubated overnight at 4 °C with primary antibodies against Neurocan (1:100; Sigma, Cat#MAB5212) and α-tubulin (1:10,000; Cat #66031–1-Ig), followed by incubation with HRP-conjugated secondary antibody (1:10,000; Bioworld, Cat #BS12478). Protein bands were visualized using ECL detection. Statistical analysis The radiomics features between the patient group and the HC group were compared using a two-sample t-test statistical analysis. This analysis was conducted with the aid of MATLAB 2020a toolboxes, including SPM, BrainNet, NBS, and GRETNA, as well as the R programming language. For voxel-based features, we applied cluster-level correction (cluster size > 20) and deemed p < 0.001 to be statistically significant. Furthermore, to identify the functional connectivity patterns associated with specific changes in patients, we employed Network-based Statistic Analysis (NBS) to control the family-wise error rate effectively. Consequently, this study investigates potential differences in graph theory characteristics between patients and HC by comparing AUC values of graph theory features across different brain regions and analyzing the changing trends of these features within the sparsity interval. Animal experiment data were expressed as standard deviation (SD). Statistical analyses were performed using GraphPad Prism 9 software. The two-tailed t-test was used for comparison between the two groups. p < 0.05 indicated a statistically significant difference. Results Comorbidity evidence between TN and depression This study aimed to identify genetic variants associated with TN through a GWAS and to conduct a joint analysis with genetic variants previously implicated in depression, thereby exploring potential shared genetic mechanisms underlying the comorbidity of TN and depression. We performed a GWAS of TN using data from the UK Biobank, including 508 clinically confirmed cases and 2,540 matched controls. The age of participants ranged from 49 to 83 years, with females accounting for 68.7% and males for 31.3% in both groups. A total of 18,433,796 genetic variants were tested for association with TN, and 17 variants reached genome-wide significance (r2 < 0.1, distance = 1000 kb, p < 5 × 10−8) (Table S1). In addition, from the PGC summary-level GWAS data for depression, 4,613 out of 8,447,782 genetic variants were identified as significantly associated with depression (p < 5 × 10−8). Previous studies have consistently underscored the substantial comorbidity burden between TN and psychiatric disorders. Among these, depression and anxiety represent the most prevalent comorbid conditions and are known to exacerbate pain severity and chronicity, thereby creating a bidirectional cycle in which nociceptive distress and emotional dysregulation mutually reinforce each other [26, 27]. Epidemiological evidence indicates that over 67% of individuals with chronic pain exhibit concurrent psychiatric symptoms, with approximately 35% presenting depressive manifestations and 22% exhibiting neurotic disorders [28]. Notably, antidepressants remain a cornerstone in the clinical management of chronic pain [7]. Collectively, these findings highlight the clinical importance of TN-depression comorbidity. To further substantiate the comorbidity between TN and depression, we have supplemented two additional analyses, bidirectional Mendelian Randomization (MR) analysis and pair-wise GWAS (GWAS-PW) analysis. MR analysis leverages genetic variants as instrumental variables to infer the causal relationship between exposure and outcome, thereby minimizing confounding and reverse causation. GWAS-PW program evaluates the posterior probabilities of different causal models to characterize whether two traits share causal variants within specific genomic regions. The corresponding methodological details were provided in the Supplementary Materials and Methods. The primary analyses consisted of two sequential steps. First, we performed a series of two-sample bidirectional MR analysis. When TN was modeled as the exposure, genetically predicted TN was associated with an increased risk of depression (OR = 1.001, p = 1.59 × 10−3, Table S2), and the directionality test supported the causal direction. In contrast, reversing the exposure–outcome relationship revealed no evidence supporting a causal effect of genetically-predicted depression on TN (OR = 1.043, p = 0.634, Table S2), and directionality testing suggested a likely incorrect causal direction. Notably, the GWAS analyses for both TN and depression were conducted in partially overlapping subsets of the UK Biobank, we therefore implemented additional methodological safeguards to minimize potential bias arising from sample overlap: (i) All instrumental SNPs used in the MR analyses were restricted to strong instruments (F > 10) [29], ensuring precise estimation of SNP-exposure associations and thereby reducing the influence of overlap-induced correlation between estimation errors. (ii) Applying multiple MR methods capable of accounting for pleiotropy and correlation among instruments. As detailed in the Supplementary Materials and Methods, we selected the most suitable MR methods based on the degree of heterogeneity and horizontal pleiotropy across instruments. Notably, horizontal pleiotropy is conceptually related to the scenario in which instruments correlate with both the exposure and the outcome, an issue that could also arise in the presence of sample overlap. The MR-Egger approach, which accommodates correlated horizontal pleiotropy, was utilized when pleiotropic effects were suspected and thus indirectly mitigated potential bias introduced by sample overlap. The MR-Egger method also revealed a significant genetic causal association when treating TN as the exposure (OR = 1.002, p = 3.58 × 10−2). We further employed the Robust Adjusted Profile Score (MR-RAPS) method, designed to provide consistent causal estimates in the presence of systematic and idiosyncratic pleiotropy as well as weak instruments. Consistent with the MR-Egger findings, MR-RAPS also identified a significant effect of genetically-predicted TN on depression risk (OR = 1.001, p = 3.27 × 10−4). The overall convergence across complementary MR methods supports the robustness and validity of the inferred causal effect of TN on depression. Second, we implemented the GWAS-PW framework to identify shared causal genomic regions between TN and depression. Using a predefined posterior probability threshold of PPA3 > 0.8, we identified 11 genomic regions harboring shared pathogenic variants (Table S3). These colocalization results further corroborate a shared genetic architecture underlying TN and depression and provide robust evidence reinforcing our comorbidity interpretation. Analysis of genetic factors for diseases based on GWAS summary statistics Using the S-PrediXcan method, we identified 518 gene-tissue association genes significantly associated with TN and 1,750 gene-tissue association genes significantly associated with depression across 13 brain regions. Pathway enrichment analysis of these genes revealed their association with several key biological processes, including metabolism, immune response, and inflammation (Fig. S1). By intersecting these two sets of genes, a total of 30 comorbidity genes were obtained (Fig. 2A). Among them, the cerebellum exhibited the largest number of comorbidity genes, totaling 7. Additionally, through the SMR method, we identified 1,354 gene-tissue association genes significantly associated with TN and 3,638 gene-tissue association genes significantly associated with depression in the same 13 brain regions. After intersecting these two sets of genes, a total of 119 comorbidity genes were obtained (Fig. 2B), with the cerebellum again showing the largest number of comorbidity genes, totaling 31. Finally, the NCAN gene, which is specifically related to the cerebellum, was identified as a common comorbidity gene by both methods, suggesting that the expression of the NCAN protein in the cerebellum may play a role in simultaneously regulating the onset and progression of TN and depression.Fig. 2Tissue associated genes common to TN and depression. (A) S-PrediXcan analysis identified 30 unique genes in 13 brain regions that were associated with both TN and depression, with the largest number of genes specifically associated with the cerebellum. (B) SMR analysis identified 119 unique genes associated with both TN and depression in 13 brain regions, with the largest number of genes specifically associated with the cerebellum. Only the 40–50 unique genes are shown. p < 0.05 Tissue associated genes common to TN and depression. (A) S-PrediXcan analysis identified 30 unique genes in 13 brain regions that were associated with both TN and depression, with the largest number of genes specifically associated with the cerebellum. (B) SMR analysis identified 119 unique genes associated with both TN and depression in 13 brain regions, with the largest number of genes specifically associated with the cerebellum. Only the 40–50 unique genes are shown. p < 0.05 Demographic characteristics of subjects This study investigated through clinical imaging data whether there were functional changes in the cerebellum of TN patients and those with depression. Based on rs-fMRI data obtained from the OpenNeuro database, this study ultimately included 58 TN patients and 51 depression patients. These data were compared with those of their respective HC groups to investigate the neuroimaging mechanisms underlying the two diseases. Statistical analysis revealed no significant differences in age or gender distribution between the TN patients and their HC group, as well as the depression patients and their corresponding HC group (p > 0.05) (Table 2). This reduces the influence of gender and age on the statistical results.Table 2Comparison of general data between patients and healthy controls. TN, trigeminal neuralgiaDemographic informationPatientsHealthy controlP-valueTNAge57.50 ± 7.4657.57 ± 12.220.154SexFemale: 30Female: 150.882Male: 28Male: 11DepressionAge32.78 ± 8.8933.81 ± 8.490.649SexFemale: 38Female: 150.796Male: 13Male: 6 Table 2Comparison of general data between patients and healthy controls. TN, trigeminal neuralgiaDemographic informationPatientsHealthy controlP-valueTNAge57.50 ± 7.4657.57 ± 12.220.154SexFemale: 30Female: 150.882Male: 28Male: 11DepressionAge32.78 ± 8.8933.81 ± 8.490.649SexFemale: 38Female: 150.796Male: 13Male: 6 Comparison of general data between patients and healthy controls. TN, trigeminal neuralgia Local neural activity analysis We initially performed two-sample t-tests to compare regional brain values of zALFF, zfALFF and szReHo between patients with TN or depression and their respective HC groups. Compared with the HC group (Table S4), TN patients exhibited significantly increased fALFF values in the right lenticular nucleus, pallidum (PAL). Conversely, fALFF values were significantly decreased in the right inferior frontal gyrus, opercular part (IFGoper). Regions with significantly increased ReHo values included the left temporal pole: medial temporal gyrus (MTGp). In depression patients, compared with the HC group (Table S5), significantly decreased ALFF values were observed in the right IFGoper and the right precentral gyrus (PreCG). Additionally, fALFF values were significantly decreased in the right IFGoper. ReHo values were significantly decreased in the left lobule IV, V of cerebellar hemisphere. In summary, voxel feature changes in TN and depression patients, relative to the corresponding HC group, were predominantly localized in the right hemisphere, particularly involving the frontal lobe. The cerebellar region also demonstrated potential voxel feature alterations in both diseases (Fig. 3, p < 0.05).Fig. 3Brain segmentation map of significant differences in voxel features. (A) Brain differentiation map with significant differences in ALFF, fALFF, and ReHo values in TN patients. (B) Brain mapping with significant differences in ALFF, fALFF, and ReHo values in patients with depression. p < 0.05. ALFF, amplitude of low-frequency fluctuation; fALFF, fractional amplitude of low-frequency fluctuation; ReHo, regional homogeneity Brain segmentation map of significant differences in voxel features. (A) Brain differentiation map with significant differences in ALFF, fALFF, and ReHo values in TN patients. (B) Brain mapping with significant differences in ALFF, fALFF, and ReHo values in patients with depression. p < 0.05. ALFF, amplitude of low-frequency fluctuation; fALFF, fractional amplitude of low-frequency fluctuation; ReHo, regional homogeneity Functional network properties analysis This study employed the GRETNA toolbox and graph theory methods to systematically analyze the characteristics of brain network. Separate comparisons were conducted for the two patient groups, TN and depression, each against their own healthy controls. To investigate the variations in graph theory features across sparsity levels, this study computed the properties of brain regions exhibiting significant differences across a sparsity threshold range of 0.1–0.5 (step = 0.01) for the TN dataset and 0.1–0.48 (step = 0.01) for the depression dataset. Notably, the graph theory features of the TN group and the depression group demonstrated σ (σ > 1) throughout the entire connectivity density interval, with statistically significant differences. Futhermore, the analysis conducted using the NBS approach revealed no significant FC alternations in either TN patients or depression patients compared to healthy controls. Further analysis was performed to examine the differences in graph-theoretical features, including BC, CC, NE, NLE, DC, and SPL, of brain networks between the two subject groups across various connectivity densities. Compared with the HC group, the TN group exhibited significantly increased BC values in specific brain regions, including the right inferior cerebellar hemisphere, the right medial and cingulate paracingulate gyri (DCG), the right supramarginal gyrus (SMG), and the left superior temporal gyrus (STG) (Fig. 4A). Conversely, brain regions showing significant decreases in BC values included the right medial frontal gyrus, orbital part (ORBsup), the left lingual gyrus (LING), the right inferior occipital gyrus (IOG), the left posterior central gyrus (PoCG), and the right superior cerebellar hemisphere. For CC values, significant increases were observed in the cerebellar vermis, the left PoCG, the left superior parietal cortex (SPG), the left inferior parietal lobule (IPL), and the left superior cerebellar hemisphere (Fig. 4B), while decreases were noted in the right inferior cerebellar hemisphere and the left STGp. Regarding NLE values, significant increases were found in the cerebellar vermis, the left SPG, the left paracentral lobule (PCL), and the right superior cerebellar hemisphere (Fig. 4C), whereas decreases occurred in the right angular gyrus (ANG) and the left inferior temporal gyrus (ITG). In terms of DC values, significant increases were identified in the left Heschl’s gyrus (HES) and the right STG (Fig. 4D). Lastly, the right STG demonstrated a significant increase in NE values (Fig. 4E).Fig. 4Brain regions showing significant differences in various graph theoretic features of TN patients. (A) Brain regions with significant differences in BC. (B) Brain regions with significant differences in CC. (C) Brain regions with significant differences in NLE. (D) brain regions with significant differences in DC. (E) Brain regions with significant differences in NE. *p < 0.05, **p < 0.01, ***p < 0.001 Brain regions showing significant differences in various graph theoretic features of TN patients. (A) Brain regions with significant differences in BC. (B) Brain regions with significant differences in CC. (C) Brain regions with significant differences in NLE. (D) brain regions with significant differences in DC. (E) Brain regions with significant differences in NE. *p < 0.05, **p < 0.01, ***p < 0.001 The depression group exhibited significant alterations with the HC group in various brain regions across multiple features. Specifically, regions with significantly increased BC values included the cerebellar vermis and the left and right thalamus (TH) (Fig. 5A). Regions with significantly decreased BC values included the left anterior cingulate and paracingulate gyrus (ACG), the left ITG, and the upper part of the right cerebellum. Regions with significantly increased DC values included the left and right ITG and the upper part of the right cerebellum (Fig. 5B). Regions with significantly decreased DC values included the right inferior frontal gyrus, orbital part (IFGorb), the left parahippocampal gyrus (PHIP), and the left and right TH. Regions with significantly increased CC values included the left lower part of the cerebellum, the cerebellar vermis, the left ACG, the left putamen (PUT), and the upper part of the right cerebellum (Fig. 5C). Regions with significantly decreased CC values included the right HES. Regions with significantly increased NE values included the right IFGorb, the left PHIP, and the left TH (Fig. 5D). Regions with significantly decreased NE values included the left lower part of the cerebellum, the right rolandic operculum (ROL), the right STG, the left and right ITG, and the upper part of the right cerebellum. Regions with significantly increased NLE values included the cerebellar vermis and the left ACG (Fig. 5E). Regions with significantly decreased NLE values included the left lower part of the cerebellum, the right HES, and the right STG. The region with significantly increased SPL value was the left ITG (Fig. 5F).Fig. 5Brain regions showing significant differences in various graph theoretic features of patients with depression. (A) Brain regions with significant differences in BC. (B) Brain regions with significant differences in DC. (C) Brain regions with significant differences in CC. (D) Brain regions with significant differences in NE. (E) Brain regions with significant differences in NLE. (F) Brain regions with significant differences in SPL. *p < 0.05, **p < 0.01, ***p < 0.001 Brain regions showing significant differences in various graph theoretic features of patients with depression. (A) Brain regions with significant differences in BC. (B) Brain regions with significant differences in DC. (C) Brain regions with significant differences in CC. (D) Brain regions with significant differences in NE. (E) Brain regions with significant differences in NLE. (F) Brain regions with significant differences in SPL. *p < 0.05, **p < 0.01, ***p < 0.001 Based on the aforementioned results, compared with the HC group, brain network alternations in both TN patients and depression patients were primarily localized to the temporal lobe, frontal lobe, and cerebellum. The CCT model showed pain-like and depression-like behaviors The mechanical pain threshold of the orofacial region in rats was assessed using von Frey filaments one day prior to surgery and on postoperative days 7, 14, 21, and 28 (Fig. 6A). There was no significant difference in the baseline pain threshold between the Sham group and TN group before surgery (p > 0.05). On the 7th day post-surgery, the baseline pain threshold decreased in both the TN and Sham groups, with no significant difference observed between them. Starting from the 14th day post-surgery, the pain threshold in the Sham group remained stable, whereas the pain threshold in the TN group continued to decline, indicating heightened sensitivity to pain stimulation. The difference in pain threshold between the two groups became statistically significant, suggesting the successful establishment of the TN rat model.Fig. 6Behavioral performance of CCT model rats. (A) Comparison of pain threshold indexes induced by mechanical compression stimulation in Sham group and TN group 1 day before surgery and 7 to 28 days after surgery. (Two-sample t-test; n = 6 TN and sham animals). (B) The original track representation of the Sham group and TN group in the open field experiment, and the comparison of the total distance and speed of movement in the open field experiment. (Two-sample t-test; n = 6 TN and sham animals). (C) The original track representation of Sham group and TN group in the elevated cross maze experiment, and the comparison of the percentage index of open arm residence time in the elevated cross maze experiment. (Two-sample t-test; n = 6 TN and sham animals). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Behavioral performance of CCT model rats. (A) Comparison of pain threshold indexes induced by mechanical compression stimulation in Sham group and TN group 1 day before surgery and 7 to 28 days after surgery. (Two-sample t-test; n = 6 TN and sham animals). (B) The original track representation of the Sham group and TN group in the open field experiment, and the comparison of the total distance and speed of movement in the open field experiment. (Two-sample t-test; n = 6 TN and sham animals). (C) The original track representation of Sham group and TN group in the elevated cross maze experiment, and the comparison of the percentage index of open arm residence time in the elevated cross maze experiment. (Two-sample t-test; n = 6 TN and sham animals). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 In the open field test, the total distance and the average movement speed in the TN group at 28th day post-surgery were significantly reduced compared to the Sham group (Fig. 6B). In the EPM test, the percentage of time spent in the open arms was also markedly lower in the TN group compared to the Sham group (Fig. 6C). These findings suggest that rats in the TN group displayed pronounced depressive-like behaviors. NCAN expression is elevated in the cerebellar tissue of the CCT model The expression levels of NCAN in the cerebellum of TN rats 28th day post-surgery were quantitatively analyzed using RT-qPCR and Western blot techniques. The RT-qPCR analysis revealed a significant increase in the mRNA expression level of NCAN in the TN group compared to the Sham group (Fig. 7A). Furthermore, Western blot results demonstrated a distinct band of NCAN protein at 165 kDa, with the relative protein expression level being significantly higher in the TN group than in the Sham group (Fig. 7B, Fig. S2). These findings suggest that chronic compression induced by TREZ can upregulate the expression of NCAN in the rat cerebellum, potentially implicating NCAN in the pathogenesis of pain and depression-like behaviors observed in the TN model.Fig. 7Upregulation of NCAN expression in TN model rats. (A) RT-qPCR analysis revealed significantly increased NCAN mRNA levels in the cerebellum of TN model rats compared with sham-operated controls at 28th day post-surgery. (Two-sample t-test; n = 3 TN and sham animals). (B) Western blot detection demonstrated elevated NCAN protein expression (single band at 165 kDa) in TN model cerebellums versus sham controls at 28th day post-operation. (Two-sample t-test; n = 5 TN and sham animals). **p < 0.01 Upregulation of NCAN expression in TN model rats. (A) RT-qPCR analysis revealed significantly increased NCAN mRNA levels in the cerebellum of TN model rats compared with sham-operated controls at 28th day post-surgery. (Two-sample t-test; n = 3 TN and sham animals). (B) Western blot detection demonstrated elevated NCAN protein expression (single band at 165 kDa) in TN model cerebellums versus sham controls at 28th day post-operation. (Two-sample t-test; n = 5 TN and sham animals). **p < 0.01 Discussion TN, one of the most severe forms of neuropathic pain, is frequently misdiagnosed as other orofacial pain conditions, thereby complicating its diagnosis and treatment. Depression, a prevalent mood disorder, exhibits complex bidirectional interactions with chronic pain, often extending the duration of pain episodes and exacerbating their intensity [5]. Adults with chronic pain have been reported to be more likely to exhibit clinical symptoms of depression [30]. Consequently, an in-depth investigation into the shared pathogenic mechanisms of TN and depression is crucial for the development of integrated therapeutic strategies targeting both disorders. Tissue-specific analysis constitutes a critical step in GWAS for elucidating gene functions. In this study, advanced methodologies such as S-PrediXcan and SMR were employed to investigate tissue-specific patterns of gene expression across 13 brain regions. These analyses identified abnormal expression of TN and depression-related genes in specific brain areas, providing molecular-level insights into the shared neurobiological mechanisms linking these two diseases. Notably, the cerebellum was found to harbor the largest number of comorbidity-associated genes. Furthermore, the expression of NCAN was specifically linked to the cerebellum, as evidenced by both tissue-specific analytical approaches. Current research has demonstrated that specific cerebellar regions, including the IV-VI lobules and Crus I, are activated during pain processing [31]. These regions are implicated in the subsequent processing of pain signals via neural circuits connecting the cerebral cortex, brainstem, and other areas. Specifically, the Crus I, Crus II, and VI lobules of the cerebellum are associated with the anticipation, perception, and emotional dimensions of pain [32]. For example, when individuals expect to experience pain, these brain regions may become activated, consequently influencing the subjective perception of pain. Moreover, the cerebellum may modulate pain affect through its connections with emotion-related brain areas, including the ACC and the amygdala [32]. These regions are implicated in pain processing, emotion regulation, and cognitive functions. Therefore, in patients with depression, aberrant cerebellar function may contribute to depressive symptoms, including low mood and anhedonia, and may also impair cognitive functions such as attention and memory. Consequently, the cerebellum may serve as a critical intermediary facilitating the interaction between pain and depression via shared neural circuits. Depressive mood may amplify the perception and emotional experience of pain, whereas chronic pain may contribute to low mood and exacerbate depressive symptoms. The cerebellum may modulate the intensity and direction of this interaction by regulating neural activities associated with emotion and pain. This study investigated alterations in brain function in both TN and depression patients by calculating local neural activity and network features. The findings revealed that all graph theory features within the temporal lobe region of TN patients exhibited significant alterations, indicating a pivotal role in brain network reorganization. Furthermore, voxel-wise analysis demonstrated increased homogeneity within the temporal lobe. This research underscores that the temporal lobe is a critical brain region associated with pain perception. Previous studies have indicated structural changes in the temporal lobe may be closely linked to the duration and progression of chronic pain. In the early stages of chronic pain, the gray matter volume of the temporal lobe may increase; however, it progressively diminishes as the pain persists [33, 34]. Positron Emission Tomography (PET) studies have demonstrated a significant correlation between the glucose metabolism level in the temporal lobe region of individuals with depression and the severity of depression symptoms [35]. These findings indicate that the temporal lobe may play a crucial role in the neurobiological mechanisms underlying TN and depression. Currently, research on NCAN predominantly centers on its roles in neural development, synapse formation, neural injury response, and neuropsychiatric disorders. Specifically, NCAN secreted by astrocytes modulates the formation and function of inhibitory synapses in the developing cortex. Following secretion, NCAN undergoes proteolytic cleavage into N-terminal and C-terminal fragments. Notably, the C-terminal fragment localizes at the synapse and plays a critical role in regulating inhibitory synapse formation [36]. In addition, NCAN is involved in regulating the organizational structure of the axon initial segment (AIS) in cortical neurons and modulating their neuronal activities. A decrease in NCAN levels triggers the remodeling of the extracellular matrix surrounding neurons and influences the expression of key proteins within the AIS, providing novel insights into its role in precisely tuning neuronal functions [37]. Other studies have reported that NCAN is upregulated in brain-injured astrocytes and those treated with cytokines, indicating its potential involvement in the neural injury response [38]. Beyond these functions, research has shown a significant association between NCAN and depression, with NCAN-deficient mice exhibiting markedly attenuated depression-like behavior [39]. In neuropathic pain, the upregulation of NCAN is an important component of the structural and functional remodeling of perineuronal nets. It may promote pain sensitization by enhancing the wrapping of GABAergic neurons [40, 41]. In this study, the CCT rat model we developed exhibited both pain-like and depression-like behaviors, characterized by a reduced pain threshold and diminished exploratory behaviors. The expression levels of NCAN in the cerebellum of the CCT model rats were assessed using qPCR and Western blot analyses. The results demonstrated that both mRNA and protein expression levels of NCAN were significantly upregulated, consistent with prior research findings [39]. This suggests that TN may influence the activity of relevant neurons by upregulating NCAN expression, thereby contributing to pain and depression-like behaviors in the CCT model. However, this study still has several limitations that warrant acknowledgment. Firstly, the whole genome data source used in this study is relatively homogeneous, being derived exclusively from the European population. Given the heterogeneity of patient populations, future studies should incorporate large-scale, multi-source datasets to validate the generalizability and robustness of the findings. Secondly, the partial sample overlap between the TN and depression GWAS datasets derived from the UK Biobank, which may introduce bias in two-sample MR analyses. Sample overlap is known to inflate weak instrument bias and increase false-positive rates in MR settings [42]. Upon careful inspection of the underlying cohorts, we confirmed a modest degree of overlap between the two datasets. To mitigate the influence of such overlap on causal effect estimation, we implemented several methodological safeguards: (i) All instrumental SNPs used in the MR analyses were restricted to strong instruments (F > 10) [29], which improved the precision of SNP–exposure estimates and reduced correlation in estimation errors induced by overlapping samples; (ii) We employed multiple MR estimators capable of addressing pleiotropy and correlation among instruments, including MR-Egger, which explicitly accommodates correlated horizontal pleiotropy [43], and the Robust Adjusted Profile Score (MR-RAPS), a method designed to produce consistent causal estimates even in the presence of both systematic and idiosyncratic pleiotropy as well as weak instruments [44]. The consistency of the causal estimates across these complementary approaches provided reassurance regarding the robustness of our MR findings. Thirdly, the precise underlying mechanism warrants further investigation. In future research, we will regulate the expression level of NCAN in CCT animal models to further observe the impact of elevated or decreased NCAN expression on pain-like or depressive-like behaviors in animals. In addition, in this study, all the experimental animals were male mice. This is because female mice experience an estrous cycle every 4 to 5 days. The fluctuating levels of estrogen and progesterone during the cycle directly affect their brains and behaviors, leading to periodic changes in their performance in behavioral tests. Behaviors affected by cycles include but are not limited to anxiety-like behaviors and pain sensitivity. Therefore, its behavioral data naturally showed greater intra-group differences than a group of male mice with relatively stable hormone levels [45, 46]. Finally, While the animal models demonstrate increased NCAN expression in the cerebellum of CCT rats, the specific roles of NCAN in TN and depression remains unclear. Future research will focus on unraveling the biological mechanisms of NCAN, providing insights into the development of integrated treatment strategies for TN and depression, as well as validating the functional relevance of the NCAN gene in clinical samples. Conclusion This study comprehensively investigates the co-pathogenic factors of TN and depression through multimodal approaches. Genomic analysis identifies comorbidity genes, with NCAN in the cerebellum being a notable finding. Imaging analysis reveals significant alterations in brain function, particularly in the temporal lobe, frontal lobe, and cerebellum. Animal experiments further validate the increased expression of NCAN in TN comorbid with depression. Despite limitations such as sample size and data homogeneity, this study provides valuable insights into the shared pathogenic mechanisms of TN and depression. Future work should focus on expanding the sample size, incorporating diverse datasets, and elucidating the biological mechanisms of identified genes to develop integrated treatment strategies. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2 Supplementary Material 3 Supplementary Material 3 Supplementary Material 4 Supplementary Material 4